Clinical Studies Search

Protocol Summary


Protocol No.
PSCI-18-127
Prinicipal Investigator
Drabick, Joseph
Phase
Phase III
Age Group
Adult
Scope
National
Secondary Protocol No.
EA6174
Title
STAMP: Surgically Treated Adjuvant Merkel cell carcinoma with Pembrolizumab, a Phase III Trial
Objective
Primary Objective:
To compare Overall Survival (OS) and Recurrence Free Survival
(RFS) as co-primary endpoints across the two arms.

Secondary Objective:
To evaluate adverse events.
To evaluate Distant Metastasis Free Survival (DMFS).
To evaluate the impact of radiation on clinical outcomes (OS, RFS,
DMFS).
Applicable Disease Sites
Other Skin
Status
Open
Participating Institutions
Hershey Medical Center